Hzymes Biotechnology Co., Ltd.
PrivateLast Round
Series C
Nov 5, 2021
Est. Valuation
$750.24M
Total Funding Raised
$125.19M
Company Overview
Hzymes Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, and production of enzyme-based raw materials for the biopharmaceutical and in vitro diagnostics industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hzymes Biotechnology Co., Ltd. Comparables
Compare Hzymes Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novoprotein Scientific Inc. | 81% | |
| Yeasen Biotechnology (Shanghai) Co., Ltd. | 81% | |
| Nanjing Vazyme Biotech Co Ltd | 78% | |
Hzymes Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 5, 2021 | ||||
| VC Round | Jul 1, 2020 | ||||
| Series B | Nov 1, 2019 | ||||
| Series A | Jul 27, 2018 | ||||
| Angel | Dec 1, 2015 |
Hzymes Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GL Capital Group | Series C |
| Guoke Jiahe Capital | Series C |
| Shanghai Science and Technology Innovation Group | Series C |
| GF Venture Capital | VC Round, Series C |
| Wuhan Guanggu Talent Fund | Angel |
| Sanze Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2020
GF Venture Capital participated in the round.
- Jul 27, 2018
Raised Series A with Sanze Venture Capital participating.
Hzymes Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hzymes Biotechnology Co., Ltd.'s valuation, stock price, and market status.